New Clinical Data Released for Spinal Fusion System
The 12-month REFINE study findings provide new insights for patients considering surgical options for lumbar spinal stenosis.
Updated on Oct. 23, 2026 in Stroke
Live Poll
Do you trust that medical device companies provide enough independent clinical evidence for their new treatments?
Results from the 12-month REFINE clinical study of the ZIP MIS Interlaminar Fusion System were recently published in The International Journal of Spine Surgery. The study followed patients managing symptomatic neurogenic claudication tied to lumbar spinal stenosis and degenerative disc disease.
Why it matters
Understanding the outcomes of spinal stabilization systems is essential for patients considering surgical options to manage chronic back pain. These findings offer updated clinical data for those currently navigating treatment paths for degenerative lumbar conditions.
The REFINE study was a prospective, observational, open-label, nonrandomized, multicenter trial following patients over a 12-month period. While these results provide new insights into the ZIP MIS Interlaminar Fusion System, the comparative efficacy against other techniques is still under investigation.
The players
Aurora Spine
A Carlsbad-based medical device company focused on developing minimally invasive solutions for spinal disorders and degenerative spine conditions.
The International Journal of Spine Surgery
A peer-reviewed publication that serves as a platform for research into new surgical techniques, clinical outcomes, and technologies in the field of spinal care.
The details
The study assessed the ZIP MIS Interlaminar Fusion System, a device designed to stabilize the lumbar spine by creating a fusion between vertebral segments. By addressing mechanical instability through this interlaminar approach, the system aims to alleviate symptoms of neurogenic claudication. The research involved tracking patients who underwent this procedure to monitor their functional recovery and symptom progression over one year.
Timeline
October 9, 2026: The REFINE study results were published online in The International Journal of Spine Surgery.
October 22, 2026: Aurora Spine announced the publication of the study results.
Health Landscape
This report provides the 12-month data output for the ongoing REFINE clinical study evaluating the ZIP MIS Interlaminar Fusion System. It contributes to the evolving body of evidence comparing minimally invasive surgical technologies against established standards for treating lumbar spinal stenosis.
Patients dealing with persistent leg pain or limited mobility due to lumbar stenosis may find these results useful when discussing surgical options with a spine specialist. It is important to ask your physician about how specific fusion devices compare to other minimally invasive surgical approaches.
The takeaway
The REFINE study highlights how minimally invasive fusion systems are being monitored for long-term patient outcomes in lumbar care. When evaluating treatment paths for degenerative disc disease, consider keeping a symptom diary to review with your surgeon before deciding on a specific procedure.
Further reading
For more information on managing spinal conditions and potential treatments, visit our Stroke section.
Live Poll
Do you trust that medical device companies provide enough independent clinical evidence for their new treatments?
